138 related articles for article (PubMed ID: 34857661)
1. Biodistribution and Radiation Dosimetry of Intraperitoneally Administered
Grkovski M; Modak S; Zanzonico PB; Carrasquillo JA; Larson SM; Humm JL; Pandit-Taskar N
J Nucl Med; 2022 Jul; 63(7):1094-1100. PubMed ID: 34857661
[TBL] [Abstract][Full Text] [Related]
2. B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study.
Modak S; Zanzonico P; Grkovski M; Slotkin EK; Carrasquillo JA; Lyashchenko SK; Lewis JS; Cheung IY; Heaton T; LaQuaglia MP; Cheung NV; Pandit-Taskar N
J Clin Oncol; 2020 Dec; 38(36):4283-4291. PubMed ID: 33119478
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution and Dosimetry of Intraventricularly Administered
Pandit-Taskar N; Zanzonico PB; Kramer K; Grkovski M; Fung EK; Shi W; Zhang Z; Lyashchenko SK; Fung AM; Pentlow KS; Carrasquillo JA; Lewis JS; Larson SM; Cheung NV; Humm JL
J Nucl Med; 2019 Dec; 60(12):1794-1801. PubMed ID: 31405921
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunoscintigraphy and Pretreatment Dosimetry of
Pandit-Taskar N; Grkovski M; Zanzonico PB; Pentlow KS; Modak S; Kramer K; Humm JL
J Nucl Med; 2023 Jun; 64(6):946-950. PubMed ID: 36759197
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using 89Zr-ibritumomab tiuxetan and PET.
Rizvi SN; Visser OJ; Vosjan MJ; van Lingen A; Hoekstra OS; Zijlstra JM; Huijgens PC; van Dongen GA; Lubberink M
Eur J Nucl Med Mol Imaging; 2012 Mar; 39(3):512-20. PubMed ID: 22218876
[TBL] [Abstract][Full Text] [Related]
6. Phase I study to assess safety, biodistribution and radiation dosimetry for
Merkx RIJ; Lobeek D; Konijnenberg M; Jiménez-Franco LD; Kluge A; Oosterwijk E; Mulders PFA; Rijpkema M
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3277-3285. PubMed ID: 33651116
[TBL] [Abstract][Full Text] [Related]
7. Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients.
Börjesson PK; Jauw YW; de Bree R; Roos JC; Castelijns JA; Leemans CR; van Dongen GA; Boellaard R
J Nucl Med; 2009 Nov; 50(11):1828-36. PubMed ID: 19837762
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution and Dosimetry of
Pandit-Taskar N; Zanzonico P; Staton KD; Carrasquillo JA; Reidy-Lagunes D; Lyashchenko S; Burnazi E; Zhang H; Lewis JS; Blasberg R; Larson SM; Weber WA; Modak S
J Nucl Med; 2018 Jan; 59(1):147-153. PubMed ID: 28705916
[No Abstract] [Full Text] [Related]
9. Phase 1 study of intraventricular
Kramer K; Pandit-Taskar N; Kushner BH; Zanzonico P; Humm JL; Tomlinson U; Donzelli M; Wolden SL; Haque S; Dunkel I; Souweidane MM; Greenfield JP; Tickoo S; Lewis JS; Lyashchenko SK; Carrasquillo JA; Chu B; Horan C; Larson SM; Cheung NV; Modak S
J Hematol Oncol; 2022 Nov; 15(1):165. PubMed ID: 36371226
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.
Bretin F; Bahri MA; Bernard C; Warnock G; Aerts J; Mestdagh N; Buchanan T; Otoul C; Koestler F; Mievis F; Giacomelli F; Degueldre C; Hustinx R; Luxen A; Seret A; Plenevaux A; Salmon E
Mol Imaging Biol; 2015 Aug; 17(4):557-64. PubMed ID: 25595813
[TBL] [Abstract][Full Text] [Related]
11. Impact of rituximab treatment on (90)Y-ibritumomab dosimetry for patients with non-Hodgkin lymphoma.
Shen S; Forero A; Meredith RF; Shah JJ; Knox SJ; Wiseman GA; Usrey ME; Lobuglio AF
J Nucl Med; 2010 Jan; 51(1):150-7. PubMed ID: 20008989
[TBL] [Abstract][Full Text] [Related]
12. PET/CT-derived whole-body and bone marrow dosimetry of 89Zr-cetuximab.
Makris NE; Boellaard R; van Lingen A; Lammertsma AA; van Dongen GA; Verheul HM; Menke CW; Huisman MC
J Nucl Med; 2015 Feb; 56(2):249-54. PubMed ID: 25613538
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor.
Herrmann K; Lapa C; Wester HJ; Schottelius M; Schiepers C; Eberlein U; Bluemel C; Keller U; Knop S; Kropf S; Schirbel A; Buck AK; Lassmann M
J Nucl Med; 2015 Mar; 56(3):410-6. PubMed ID: 25698782
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans.
Doss M; Kolb HC; Zhang JJ; Bélanger MJ; Stubbs JB; Stabin MG; Hostetler ED; Alpaugh RK; von Mehren M; Walsh JC; Haka M; Mocharla VP; Yu JQ
J Nucl Med; 2012 May; 53(5):787-95. PubMed ID: 22499613
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers.
Doss M; Kolb HC; Walsh JC; Mocharla V; Fan H; Chaudhary A; Zhu Z; Alpaugh RK; Lango MN; Yu JQ
J Nucl Med; 2013 Dec; 54(12):2087-92. PubMed ID: 24136934
[TBL] [Abstract][Full Text] [Related]
16. Radiation Dosimetry and Biodistribution of
Meyer C; Dahlbom M; Lindner T; Vauclin S; Mona C; Slavik R; Czernin J; Haberkorn U; Calais J
J Nucl Med; 2020 Aug; 61(8):1171-1177. PubMed ID: 31836685
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution, Dosimetry, and Pharmacokinetics of
Izquierdo-Garcia D; Désogère P; Fur ML; Shuvaev S; Zhou IY; Ramsay I; Lanuti M; Catalano OA; Catana C; Caravan P; Montesi SB
J Nucl Med; 2023 May; 64(5):775-781. PubMed ID: 37116909
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule 68Ga-ABY-025 in Breast Cancer Patients.
Sandström M; Lindskog K; Velikyan I; Wennborg A; Feldwisch J; Sandberg D; Tolmachev V; Orlova A; Sörensen J; Carlsson J; Lindman H; Lubberink M
J Nucl Med; 2016 Jun; 57(6):867-71. PubMed ID: 26912439
[TBL] [Abstract][Full Text] [Related]
19. Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest dose.
Rajendran JG; Gopal AK; Fisher DR; Durack LD; Gooley TA; Press OW
J Nucl Med; 2008 May; 49(5):837-44. PubMed ID: 18413376
[TBL] [Abstract][Full Text] [Related]
20. Combined model-based and patient-specific dosimetry for
Plyku D; Mena E; Rowe SP; Lodge MA; Szabo Z; Cho SY; Pomper MG; Sgouros G; Hobbs RF
Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):989-998. PubMed ID: 29460025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]